Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 10
«Preious | of 2 |
1

The Role of Gemcitabine in the First Line Treatment of Metastatic Breast Cancer

Drug Evaluation, Volume 09, Issue 6,2012, Pages 16-18, doi:10.3969/j.issn.1672-2809.2012.06.005

2

药品评价(肿瘤版)杂志编辑出版介绍

Drug Evaluation, Volume 09, Issue 6,2012, Pages 前插1,

3

Bevacizumab for Breast Cancer

Drug Evaluation, Volume 09, Issue 6,2012, Pages 21-23, doi:10.3969/j.issn.1672-2809.2012.06.007

4

Progress in Medical Treatment of Breast Cancer

Drug Evaluation, Volume 09, Issue 6,2012, Pages 4-6,9, doi:10.3969/j.issn.1672-2809.2012.06.001

5

SABCS: Latest Results from Clinical Rials with Bisphosphonates

Drug Evaluation, Volume 09, Issue 6,2012, Pages 24-25, doi:10.3969/j.issn.1672-2809.2012.06.008

Items 1-5 of 10
«Preious | of 2 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn